Drug intelligence / Profile preview

cornus mas

Development stage
Preclinical
Modality
Small Molecules, Recombinant Proteins and Enzymes
Administration
Oral, Topical
01

Overview

Cornus mas, commonly known as the Cornelian cherry or European cornel, is a deciduous shrub or small tree native to southern Europe and southwest Asia. It has been used for over a thousand years in traditional medicine systems across Europe and Asia. The fruits, leaves, flowers, seeds, and bark of Cornus mas are rich in bioactive compounds including anthocyanins (notably cyanidin 3-O-galactoside and pelargonidin 3-O-galactoside), iridoids (such as loganic acid and cornuside), flavonoids (quercetin and kaempferol derivatives), phenolic acids, vitamins (C, E, B1, B2), minerals (iron and calcium), rutin, oxalic acid and other antioxidants[1][4][8]. The plant exhibits multiple pharmacological activities such as antioxidant[1][4][8], anti-inflammatory[1][5], antidiabetic[2][4][5], hypolipidemic/antihyperlipidemic[4][5], hepatoprotective[3][4], antimicrobial/antibacterial[6][8], antiparasitic[1], anticancer/cytoprotective effects[1]. Mechanistically these effects are attributed to its ability to scavenge free radicals; modulate inflammatory pathways including inhibition of NF-κB activity; improve lipid profiles via PPAR-α activation; support vascular health through endothelium-dependent nitric oxide signaling; reduce blood glucose levels likely by improving pancreatic function; protect liver cells from oxidative damage; inhibit microbial growth. Traditionally it has been used for diarrhea,[1] gastrointestinal disorders,[7] fever,[3] malaria,[3] kidney stones,[3] urinary tract infections,[3] cancer prevention/support,[1] bleeding disorders,[1] heat stroke/sunstroke,[5] anemia/rickets/measles/chickenpox/digestion problems/sore throats/wounds/colitis/stomach ulcers.[6] Cornus mas is not an approved pharmaceutical drug but is widely consumed as a dietary supplement or functional food ingredient.

Other names
Cornelian cherryCornelian cherry dogwoodEuropean cornelZoghal Akhteh
02

Targets

AcetylcholinesteraseNF-κBPPARA (Peroxisome proliferator-activated receptor alpha)

Beyond the preview

Go deeper on cornus mas.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cornus mas.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call